HPS1
Basic information
Region (hg38): 10:98410939-98446963
Previous symbols: [ "HPS" ]
Links
Phenotypes
GenCC
Source:
- Hermansky-Pudlak syndrome 1 (Definitive), mode of inheritance: AR
- Hermansky-Pudlak syndrome 1 (Strong), mode of inheritance: AR
- Hermansky-Pudlak syndrome with pulmonary fibrosis (Supportive), mode of inheritance: AR
- Hermansky-Pudlak syndrome 1 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hermansky-Pudlak syndrome 1 | AR | Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic; Pharmacogenomic; Pulmonary | Prevention and treatment of bleeding episodes (eg, with DDAVP or platelet/RBC transfusions) can be effective, and aspirin-containing products should be avoided; Skin surveillance and protection can be beneficial; Prompt treatment of pulmonary infections (as well as avoidance of cigarette smoke) to maximize pulmonary function is indicated, including influenza and pneumococcus vaccination; Surveillance related to ophthalmologic, gastrointestinal, and other manifestations has been recommended in all individuals with HPS; Lung transplantation has been described | Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic; Pulmonary | 3921802; 2916560; 8896559; 9562579; 9497254; 10411151; 10768343; 11414528; 12126938; 16210149; 19398212; 19729668; 20301464; 20514622; 20662851; 21833017 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (63 variants)
- Hermansky-Pudlak syndrome 1 (14 variants)
- Hermansky-Pudlak syndrome (13 variants)
- Hermansky-Pudlak syndrome with pulmonary fibrosis (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HPS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 315 | 324 | ||||
missense | 216 | 12 | 241 | |||
nonsense | 25 | 16 | 41 | |||
start loss | 0 | |||||
frameshift | 38 | 36 | 76 | |||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 26 | 29 | ||||
splice region | 1 | 2 | 7 | 59 | 5 | 74 |
non coding | 33 | 164 | 57 | 255 | ||
Total | 67 | 86 | 255 | 493 | 67 |
Highest pathogenic variant AF is 0.000361
Variants in HPS1
This is a list of pathogenic ClinVar variants found in the HPS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-98410950-C-T | not specified | Uncertain significance (Mar 23, 2023) | ||
10-98415012-C-A | not specified | Uncertain significance (Mar 21, 2024) | ||
10-98415012-C-G | not specified | Uncertain significance (Sep 20, 2023) | ||
10-98415024-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
10-98415071-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
10-98415122-C-G | not specified | Uncertain significance (Feb 17, 2023) | ||
10-98416238-G-T | Hermansky-Pudlak syndrome 1 | Benign (Jan 13, 2018) | ||
10-98416315-C-T | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
10-98416329-C-T | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
10-98416347-A-G | Hermansky-Pudlak syndrome 1 | Benign (Jan 12, 2018) | ||
10-98416347-AGG-GGA | Hermansky-Pudlak syndrome | Uncertain significance (Jun 14, 2016) | ||
10-98416349-G-A | Hermansky-Pudlak syndrome 1 | Benign (Jan 13, 2018) | ||
10-98416352-A-T | Hermansky-Pudlak syndrome 1 | Uncertain significance (Apr 27, 2017) | ||
10-98416397-C-T | Hermansky-Pudlak syndrome 1 | Benign (Jan 13, 2018) | ||
10-98416479-C-T | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
10-98416521-G-A | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
10-98416559-T-C | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
10-98416563-C-A | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
10-98416582-A-G | Hermansky-Pudlak syndrome 1 | Benign (Jan 13, 2018) | ||
10-98416596-C-T | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
10-98416609-T-C | Hermansky-Pudlak syndrome 1 | Benign (Jan 13, 2018) | ||
10-98416612-A-C | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
10-98416621-G-A | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
10-98416648-C-T | Hermansky-Pudlak syndrome 1 | Benign (Jan 12, 2018) | ||
10-98416796-T-C | Hermansky-Pudlak syndrome 1 | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HPS1 | protein_coding | protein_coding | ENST00000325103 | 18 | 30730 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.32e-7 | 1.00 | 125671 | 0 | 77 | 125748 | 0.000306 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.116 | 401 | 408 | 0.984 | 0.0000265 | 4511 |
Missense in Polyphen | 151 | 151.46 | 0.99696 | 1765 | ||
Synonymous | -0.604 | 191 | 181 | 1.06 | 0.0000120 | 1425 |
Loss of Function | 3.07 | 18 | 38.6 | 0.467 | 0.00000193 | 422 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000619 | 0.000618 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000165 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000389 | 0.000378 |
Middle Eastern | 0.000165 | 0.000163 |
South Asian | 0.000330 | 0.000327 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the BLOC-3 complex, a complex that acts as a guanine exchange factor (GEF) for RAB32 and RAB38, promotes the exchange of GDP to GTP, converting them from an inactive GDP-bound form into an active GTP-bound form. The BLOC-3 complex plays an important role in the control of melanin production and melanosome biogenesis and promotes the membrane localization of RAB32 and RAB38 (PubMed:23084991). {ECO:0000269|PubMed:23084991}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;RAB GEFs exchange GTP for GDP on RABs
(Consensus)
Recessive Scores
- pRec
- 0.159
Intolerance Scores
- loftool
- 0.813
- rvis_EVS
- 0.85
- rvis_percentile_EVS
- 88.49
Haploinsufficiency Scores
- pHI
- 0.566
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.461
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.637
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hps1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype;
Gene ontology
- Biological process
- lysosome organization;visual perception;response to stimulus;melanosome assembly
- Cellular component
- cytoplasm;lysosome;cytosol;BLOC-3 complex;cytoplasmic vesicle
- Molecular function
- guanyl-nucleotide exchange factor activity;protein binding;protein dimerization activity